|
Special
DDS capabilities-Mebiopharm > Introduction
|
|
@ |
|
|
@
Pharmaceuticals are
crucial to the protection of peoplefs lives and
health, contributing greatly to our quality of
life (QOL). Numerous diseases remain
difficult to treat, and a great many patients
await new developments in the hope that the future
will bring more effective medicines.
This is particularly so in Japan, which faces the
issues associated with an aging society. In order
to build an active society abundant in the joys of
life, it is crucial that we develop medicines to
treat so-called lifestyle-related illnesses, such
as cancer, heart disease and diabetes.
Mebiopharm is a biotechnology firm involved in the
development of medicines that hold promise for
such a society, and we place a particular emphasis
on anticancer drugs with special DDS capabilities.
As a company with research and development as our
foundation, our mission is to develop
revolutionary new liposome products with special
DDS capabilities. Working in cooperation with
domestic and international universities and
researchers our ultimate goal is to contribute to
the effectiveness of medical practice and the QOL
of people everywhere by marketing these products
worldwide.
@
|
Tadashi Fujisawa
CEO
Mebiopharm Co., Ltd.
|
@
|
|
|
@ |
|
|
